The FGF3 gene helps guide early development, especially of the inner ear, outer ear, and some parts of the face and teeth. If this gene does not work properly, a baby may be born with major inner ear changes that can lead to severe hearing loss, along with small outer ears and smaller teeth. Certain inherited variants in both copies of the FGF3 gene are linked to a rare condition called LAMM syndrome. FGF3 is mainly known in medical genetics rather than popular culture.
What is a gene?
A gene is a section of DNA that carries instructions cells use to make molecules or manage activities in the body. Some genes provide the directions for producing proteins, which do much of the work inside cells. Others are mainly involved in regulating when certain activities happen, where they happen, and how active they are. Taken together, genes affect how the body grows and works, and they can influence how you respond to food, stress, or medicines. For a deeper look at this topic, more information is available in the LearnHub.
Overview
FGF3Gene function
What if the gene works
The FGF3 gene helps guide early growth of the inner ear, teeth, and parts of the head and neck. Its protein sends signals that support normal tissue development before birth.
Risk
What if the gene does not work
Changes in the FGF3 gene can disrupt inner ear, outer ear, and tooth development, leading to hearing loss with small or absent ears and small or missing teeth. Effects can range from milder to more pronounced depending on the variant.
Treatment
What does that mean for your treatment
No FGF3-specific treatment or drug choice is currently established for people with a pathogenic variant in the FGF3 gene. FGF3 is being studied in cancer research as a marker and possible drug target, but this has not led to treatment guidance for inherited FGF3 loss-of-function variants.
Conditions associated with FGF3
Gene function
What if the gene works
FGF3 helps cells share growth instructions while the body is forming. These signals are especially important early in development, when tissues need clear timing and position cues. Understanding FGF3 gene function helps show how cells build body structures in an orderly way.
The FGF3 gene makes a signaling protein that nearby cells can receive. This protein helps cells know when to grow, move, or change their activity during development.
A central part of FGF3 gene function is guiding early body patterning, which means helping tissues form in the right place. It supports the organized layout of developing structures as an embryo grows.
FGF3 signals help immature cells take on more specific roles. This supports the formation of tissues that need different cell types working together in a coordinated way.
During early development, FGF3 helps shape parts of the head and inner ear. It also contributes to the coordinated building of nearby structures in the head and neck.
What is a variant?
A genetic variant is a minor difference in the DNA sequence of a gene. These differences are common and help shape normal human variation, including differences in appearance, metabolism, and the way the body responds to environmental influences. Many have no noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene functions more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the FGF3 gene can reduce or stop production of its growth signal, or change the protein’s shape so it becomes unstable or cannot bind well to partner molecules. What happens if the FGF3 gene does not work can range from partial to near complete loss of signaling. Milder variants may leave some activity intact, while more severe variants are often linked to earlier and more marked features of LAMM syndrome.
How variants are linked to conditions
When both copies of the FGF3 gene carry pathogenic variants, this causes LAMM syndrome, a rare inherited condition linked to severe hearing loss from birth, very small or absent outer ears, and small teeth. In practice, FGF3 gene variants linked to hearing loss are most strongly associated with this specific syndrome rather than with common adult hearing loss. A confirmed result helps explain the pattern of ear, hearing, and dental findings within a family.
A variant is not necessarily a diagnosis
Genetic variants are a usual part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, having a variant linked to a condition suggests a possible association rather than a definite diagnosis, especially when multiple genes and environmental factors are involved. In some situations, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For FGF3, risk is mainly shaped by inheritance: a child is affected when they inherit certain changed copies from both parents. There is not broadly confirmed evidence that lifestyle or environmental factors meaningfully increase or lower this gene-related risk.
Inheritance of FGF3 variants
FGF3-related hearing and ear development conditions are inherited in an autosomal recessive pattern. In practical terms, the FGF3 inheritance pattern usually means a child must inherit one altered copy of the FGF3 gene from each parent to have the condition, while parents with one altered copy are typically carriers. When both parents carry an FGF3 variant, each pregnancy has a 25% chance of the child inheriting both altered copies, a 50% chance of being a carrier, and a 25% chance of inheriting neither altered copy. Because the FGF3 gene is on chromosome 11, inheritance is the same for males and females.
What does my FGF3 result mean for my family?
For FGF3, the main well-established family pattern is recessive, which means parents are often healthy carriers of the same gene change. Brothers and sisters may also have the condition or be carriers, and other blood relatives may be carriers too. Because of that, family members may want to learn whether the same FGF3 change runs in the family.
Genetic information
Genetic testing
How you find out about variants
Testing for variants in the FGF3 gene can help clarify whether inherited hearing loss or related ear and tooth findings have a genetic cause. An FGF3 genetic test usually uses blood, saliva, or a cheek swab, and the lab reads the gene's DNA sequence to look for relevant variants.
When should I consider getting a genetic test?
Genetic testing for the FGF3 gene may be worth considering when a baby is born with severe hearing loss, very small or unusually shaped outer ears, or inner ear changes seen on scans, especially if small teeth or a family history are also present. Testing can help confirm whether FGF3 is the cause.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it reveals varies by the condition and the type of variant involved. Many factors, including lifestyle, environment, age, and medical history, influence how the body works over time. In some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas like medication response, genetic results can also help put individual experiences in perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same drug may work well for one person, do little for another, or cause more side effects in someone else. Differences in how the body breaks down, moves, or responds to a medicine are common and can shape both treatment benefit and medicine sensitivity. Pharmacogenetics studies these inherited differences to help make medication use more individualized.
What is Pharmacogenetics?
Pharmacogenetics studies how differences in genes can affect the way a person responds to medications. It examines gene and drug patterns to help explain why the same treatment may work differently from one person to another. For many medicines, genes can influence both how strongly a drug works and how the body processes it. This information can help support more informed, more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the FGF3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so general medication concerns are best discussed with your doctor.
History
FGF3 entered genetics research in the 1980s, when scientists studying mouse mammary tumors identified a nearby gene called INT2. From these first observations, research expanded steadily, and INT2 was later renamed the FGF3 gene as its place in a larger gene family became clear. This work helped connect cancer research with broader studies of human development and inherited conditions. In the 2000s, pathogenic variants in the FGF3 gene were linked to a rare inherited condition involving hearing loss and changes in ear and tooth development. Over time, descriptions became more precise as DNA testing allowed doctors to match specific FGF3 variants with clinical findings. These historical steps shaped today’s understanding of FGF3 in medical genetics.